Want to join the conversation?
$STI 2Q15 Q&A Update – Aleem, CFO: Loan growth going forward - Enjoying right now is the ability to grow our direct consumer business at a nice pace & that business generates not only new consumer relationships for us, but also a relatively low cost & relatively high ROA. We’re able to move the lower ROA businesses or loans off our balance sheet.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.